《Progress In Neuro-psychopharmacology & Biological Psychiatry》雜志的最新年發文量為160篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在臨床神經病學領域的學術影響力。
該刊聚焦于醫學-臨床神經病學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 約1月 。
Progress In Neuro-psychopharmacology & Biological Psychiatry 雜志發文統計
文章名稱引用次數
- The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression35
- Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis30
- PSD95: A synaptic protein implicated in schizophrenia or autism?27
- Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis26
- Chronic pain and suicide risk: A comprehensive review26
- Differentiating between bipolar and unipolar depression in functional and structural MRI studies26
- The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions24
- Dendritic spines: Revisiting the physiological role22
- Transdiagnostic and diagnosis-specific dynamic functional connectivity anchored in the right anterior insula in major depressive disorder and bipolar depression21
- Evaluating psychosocial contributions to chronic pain outcomes21
國家/地區發文量
- USA204
- CHINA MAINLAND142
- Canada93
- Brazil87
- France59
- GERMANY (FED REP GER)55
- England49
- Australia48
- Italy40
- Spain40
